Canaccord Genuity Cuts Price Target on St. Jude Medical (STJ) Following In-Line 3Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
St. Jude Medical Reports Third Quarter 2015 Results
October 21, 2015 7:15 AM EDTST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for its third quarter ended October 3, 2015. The company announced on October 8, 2015, that it had completed its acquisition of Thoratec, which did not affect the operational results of the companys third quarter.
Third quarter 2015 highlights:
Net sales increased by approximately 6 percent on a constant currency basis compared to the prior year quarter CardioMEMS HF System sales totaled approximately $20 million Worldwide neuromodulation revenue... More